4 Magic Mushroom Stocks You Might’ve Missed In December 2020

If you’re looking for magic mushroom stocks to buy, you’re likely to be hunting for penny stocks right now. The vast majority of these psychedelic names are under $5 right now. With the exception of a select bunch, including Peter Thiel-backed Compass Pathways (CMPS Stock Report), your choices are limited if you’re searching for stocks over $5. Much like we saw during the early days of marijuana stocks, magic mushroom stocks are on the “fringe” with only some testing the waters right now. 

But the fact remains, while we’ve continued following the early evolution of this trend, the similarities are unmistakable compared to pot stocks. This isn’t only specific to the stocks but the initial focus. Think back to the early days where marijuana stocks “would never make it” according to the talking heads on TV. The main focus for many was first on the biotechnology aspect of cannabis. Fast-forward to 2020 and now recreational weed is in the same conversation as buying a bottle of wine or 6-pack of beer in many states.

Will we start seeing psychedelic products on shelves tomorrow? In short, no, but microdosing and psychedelic-assisted therapy is now hitting the mainstream. There are already a few companies gaining in early popularity due to who’s backing them. For instance, MindMed (OTC:MMEDF Stock Report) is a company we’ve discussed since its IPO.